ArticleJournal of the National Cancer Institute2020

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade.

Aleix Prat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.